UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.413

Sortiert nach

Hypertension, obesity and prostate cancer biochemical recurrence after radical prostatectomy

Prostate cancer and prostatic diseases, 2013-03, Vol.16 (1), p.62-66

2013

Volltextzugriff (PDF)

Prostate Cancer Susceptibility Locus on Chromosome 1q: a Confirmatory Study

JNCI : Journal of the National Cancer Institute, 1997-07, Vol.89 (13), p.955-959

1997

Volltextzugriff (PDF)

Androgen deprivation therapy for prostate cancer results in significant loss of bone density

Urology (Ridgewood, N.J.), 1999-10, Vol.54 (4), p.607-611

1999

Volltextzugriff (PDF)

Integrative molecular profiling of routine clinical prostate cancer specimens

Annals of oncology, 2015-06, Vol.26 (6), p.1110-1118

2015

Volltextzugriff (PDF)

Somatic mutations in the BRCA1 gene in sporadic ovarian tumours

Nature genetics, 1995-04, Vol.9 (4), p.439-443

1995

Volltextzugriff (PDF)

Prevalence of clinically actionable germline pathogenic variants (PVs) in advanced prostate cancer (aPC)

Annals of oncology, 2018-10, Vol.29, p.viii294-viii294

2018

Volltextzugriff (PDF)

Hereditary prostate cancer in African American families: linkage analysis using markers that map to five candidate susceptibility loci

British journal of cancer, 2004-01, Vol.90 (2), p.510-514

2004

Volltextzugriff (PDF)

Linkage Analysis of 153 Prostate Cancer Families Over a 30-cM Region Containing the Putative Susceptibility Locus HPCX

Clinical cancer research, 1999-12, Vol.5 (12), p.4013-4020

1999

Volltextzugriff (PDF)

Distinct regions of allelic loss on 13q in prostate cancer

Cancer research (Chicago, Ill.), 1996-03, Vol.56 (5), p.1142-1145

1996

Volltextzugriff (PDF)

The Polymorphic Exon 1 Androgen Receptor CAG Repeat in Men with a Potential Inherited Predisposition to Prostate Cancer

Cancer epidemiology, biomarkers & prevention, 2000-04, Vol.9 (4), p.439-442

2000

Volltextzugriff (PDF)

Genetic variation in adiponectin ( ) and the type 1 receptor ( ), obesity and prostate cancer in African Americans

Prostate cancer and prostatic diseases, 2010-12, Vol.13 (4), p.362-368

2010

Volltextzugriff (PDF)

Comparative Analysis of Type 2b von Willebrand Disease Mutations: Implications for the Mechanism of von Willebrand Factor Binding to Platelets

Blood, 1996-03, Vol.87 (6), p.2322-2328

1996

Volltextzugriff (PDF)

Identification and characterization of proximal 6q deletions in prostate cancer

Cancer research (Chicago, Ill.), 1996-09, Vol.56 (18), p.4150-4153

1996

Volltextzugriff (PDF)

THE NATURAL HISTORY OF LOWER URINARY TRACT SYMPTOMS IN BLACK AMERICAN MEN: RELATIONSHIPS WITH AGING, PROSTATE SIZE, FLOW RATE AND BOTHERSOMENESS

The Journal of urology, 2001-05, Vol.165 (5), p.1521-1525

2001

Volltextzugriff (PDF)

X-linked inhibitor of apoptosis deficiency in the TRAMP mouse prostate cancer model

Cell death and differentiation, 2008-05, Vol.15 (5), p.831-840

2008

Volltextzugriff (PDF)

A region of interstitial 17q25 allelic loss in ovarian tumors coincides with a defined region of loss in breast tumors

Oncogene, 1997-04, Vol.14 (16), p.1991-1994

1997

Volltextzugriff (PDF)

Polymorphisms in the prostate-specific antigen gene promoter do not predict serum prostate-specific antigen levels in African-American men

Prostate cancer and prostatic diseases, 2006-03, Vol.9 (1), p.50-55

2006

Volltextzugriff (PDF)

Absence of truncating BRIP1 mutations in chromosome 17q-linked hereditary prostate cancer families

British journal of cancer, 2009-12, Vol.101 (12), p.2043-2047

2009

Volltextzugriff (PDF)

Combined Genome-Wide Scan for Prostate Cancer Susceptibility Genes

JNCI : Journal of the National Cancer Institute, 2004-08, Vol.96 (16), p.1240-1247

2004

Volltextzugriff (PDF)

The molecular defect in type IIB von Willebrand disease : identification of four potential missense mutations within the putative GpIb binding domain

The Journal of clinical investigation, 1991-04, Vol.87 (4), p.1227-1233

1991

Volltextzugriff (PDF)

RNASEL mutations in hereditary prostate cancer

Journal of medical genetics, 2003-03, Vol.40 (3), p.e21-21

2003

Volltextzugriff (PDF)

Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics

Human molecular genetics, 2007-06, Vol.16 (11), p.1271-1278

2007

Volltextzugriff (PDF)

REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants

American journal of human genetics, 2016-10, Vol.99 (4), p.877-885

2016

Volltextzugriff (PDF)

Absence of PTEN Germ-Line Mutations in Men with a Potential Inherited Predisposition to Prostate Cancer

Clinical cancer research, 1999-06, Vol.5 (6), p.1387-1391

1999

Volltextzugriff (PDF)

Functional Analysis of a Type IIB Von Willebrand Disease Missense Mutation: Increased Binding of Large Von Willebrand Factor Multimers to Platelets

Proceedings of the National Academy of Sciences - PNAS, 1992-04, Vol.89 (7), p.2869-2872

1992

Volltextzugriff (PDF)

1 – 25 von 1.413

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.255)
Mit Volltextzugriff
(1.194)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.412)
Japanisch
(188)
Deutsch
(2)
Französisch
(1)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(852)
Life Sciences & Biomedicine
(714)
Humans
(624)
Male
(371)
Biological And Medical Sciences
(329)
Female
(303)
Medical Sciences
(252)
Animals
(214)
Adult
(207)
Middle Aged
(193)
Aged
(158)
Surgery
(101)
Mice
(95)
Physical Sciences
(87)
Fundamental And Applied Biological Sciences. Psychology
(86)
Child
(76)
Adolescent
(75)
Biochemistry & Molecular Biology
(71)
Orthopedics
(63)
Risk Factors
(63)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Hypertension, obesity and prostate cancer biochemical recurrence after radical prostatectomy

Prostate Cancer Susceptibility Locus on Chromosome 1q: a Confirmatory Study

Androgen deprivation therapy for prostate cancer results in significant loss of bone density

Integrative molecular profiling of routine clinical prostate cancer specimens

Somatic mutations in the BRCA1 gene in sporadic ovarian tumours

Prevalence of clinically actionable germline pathogenic variants (PVs) in advanced prostate cancer (aPC)

Hereditary prostate cancer in African American families: linkage analysis using markers that map to five candidate susceptibility loci

Linkage Analysis of 153 Prostate Cancer Families Over a 30-cM Region Containing the Putative Susceptibility Locus HPCX

Distinct regions of allelic loss on 13q in prostate cancer

The Polymorphic Exon 1 Androgen Receptor CAG Repeat in Men with a Potential Inherited Predisposition to Prostate Cancer

Genetic variation in adiponectin ( ) and the type 1 receptor ( ), obesity and prostate cancer in African Americans

Comparative Analysis of Type 2b von Willebrand Disease Mutations: Implications for the Mechanism of von Willebrand Factor Binding to Platelets

Identification and characterization of proximal 6q deletions in prostate cancer

THE NATURAL HISTORY OF LOWER URINARY TRACT SYMPTOMS IN BLACK AMERICAN MEN: RELATIONSHIPS WITH AGING, PROSTATE SIZE, FLOW RATE AND BOTHERSOMENESS

X-linked inhibitor of apoptosis deficiency in the TRAMP mouse prostate cancer model

A region of interstitial 17q25 allelic loss in ovarian tumors coincides with a defined region of loss in breast tumors

Polymorphisms in the prostate-specific antigen gene promoter do not predict serum prostate-specific antigen levels in African-American men

Absence of truncating BRIP1 mutations in chromosome 17q-linked hereditary prostate cancer families

Combined Genome-Wide Scan for Prostate Cancer Susceptibility Genes

The molecular defect in type IIB von Willebrand disease : identification of four potential missense mutations within the putative GpIb binding domain

RNASEL mutations in hereditary prostate cancer

Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics

REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants

Absence of PTEN Germ-Line Mutations in Men with a Potential Inherited Predisposition to Prostate Cancer

Functional Analysis of a Type IIB Von Willebrand Disease Missense Mutation: Increased Binding of Large Von Willebrand Factor Multimers to Platelets

Suchergebnisse filtern